2.3 months], but did show borderline significance for improved OS [HR, 0.40 (95% CI, 0.20–0.81), median OS 11.4 vs. 3.0 months] ( Fig 4C and D ).
← all excerpts
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics.
1
—
—